Insights on digital supply chain transformation
Controlant, a global leader in the digital transformation of pharma supply chains, in collaboration with a consortium of partners including Deutsche Telekom, one of the world's leading integrated telecommunications companies, announces at Mobile World Congress 2024 in Barcelona a transformative innovation to bring real-time, end-to-end visibility to pharma supply chains.
Hubert Nafalski, Chapter Lead & Site Manager, discusses his role at Controlant. He talks about how gratified he is in playing a role in ensuring that medicines and vaccines reach those who need them.
The clinical trial market is in a state of flux; innovative therapies, working practices and startups are creating a landscape of constant churn. To navigate it, supply chain optimisation will be essential.
Controlant affirms its commitment to environmental transparency by disclosing its environmental impact through the Climate Disclosure Project (CDP), a global non-profit that runs the world’s leading environmental disclosure platform. In the first year of rating, CDP rates Controlant B- for its coordinated action on climate issues.
New technology is sometimes sluggish to penetrate the pharmaceutical industry. With an era of digital transformation promising to optimize pharmaceutical supply chains, how are companies learning to embrace the change?
Controlant has been rated Silver in its 2024 EcoVadis sustainability assessment, placing the company among the top 15% of over 125,000 rated companies across industries. The Silver rating is a significant achievement in the second assessment year for Controlant, bumping the company up from a Bronze rating in the previous year. The rating is in line with Controlant ambitions to become a sustainability leader.